Gene Therapies in Clinical Development to Treat Retinal Disorders

Gene Therapies in Clinical Development to Treat Retinal Disorders

Gene therapies have emerged as promising treatments in clinical development for various retinal disorders, offering hope to patients with inherited degenerative eye conditions. Several gene therapies have already shown remarkable success in clinical trials, with significant improvements observed in...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	McClements, ME, Elsayed, MEAA, Major, L, de la Camara, CM, MacLaren, RE
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Springer 2024

Eitemau Tebyg

Gene therapy for retinal disease.
gan: McClements, M, et al.
Cyhoeddwyd: (2013)

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
gan: Orlans, HO, et al.
Cyhoeddwyd: (2021)

RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences
gan: Fry, LE, et al.
Cyhoeddwyd: (2020)

Genome-editing strategies for treating human retinal degenerations
gan: Quinn, J, et al.
Cyhoeddwyd: (2021)

Minicircle delivery to the neural retina as a gene therapy approach
gan: Staurenghi, F, et al.
Cyhoeddwyd: (2022)

Gene therapy for retinal dystrophies
gan: Issa, P, et al.
Cyhoeddwyd: (2012)

Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa
gan: Fischer, MD, et al.
Cyhoeddwyd: (2017)

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
gan: Chandler, LC, et al.
Cyhoeddwyd: (2021)

Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy
gan: Chandler, L, et al.
Cyhoeddwyd: (2020)

Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes
gan: McClements, M, et al.
Cyhoeddwyd: (2017)

Cell-mediated inflammatory response to AAV gene therapy in the retina
gan: Chandler, LC, et al.
Cyhoeddwyd: (2020)

Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
gan: Fry, LE, et al.
Cyhoeddwyd: (2025)

Clinical applications of retinal gene therapy.
gan: Lipinski, D, et al.
Cyhoeddwyd: (2013)

An analysis of retinal gene therapy clinical trials.
gan: Maclaren, R
Cyhoeddwyd: (2009)

Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases
gan: Xue, K, et al.
Cyhoeddwyd: (2020)

Gene therapy for age-related macular degeneration
gan: MacLaren, RE
Cyhoeddwyd: (2015)

Association of a novel intronic variant in RPGR with hypomorphic phenotype of x-linked retinitis pigmentosa
gan: Cehajic-Kapetanovic, J, et al.
Cyhoeddwyd: (2020)

RPGR gene therapy presents challenges in cloning the coding sequence
gan: Martinez-Fernandez De La Camara, C, et al.
Cyhoeddwyd: (2019)

Insights on the regeneration potential of Müller glia in the mammalian retina
gan: Salman, A, et al.
Cyhoeddwyd: (2021)

Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy
gan: De Silva, SR, et al.
Cyhoeddwyd: (2017)

Technique of retinal gene therapy: delivery of viral vector into the subretinal space
gan: Xue, K, et al.
Cyhoeddwyd: (2017)

Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
gan: Taylor, LJ, et al.
Cyhoeddwyd: (2023)

Potential CRISPR base editing therapeutic options in a Sorsby fundus dystrophy patient
gan: Elsayed, MEAA, et al.
Cyhoeddwyd: (2022)

[Gene therapy for retinal dystrophies].
gan: Charbel Issa, P, et al.
Cyhoeddwyd: (2012)

Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy.
gan: Simunovic, M, et al.
Cyhoeddwyd: (2017)

Clinical characterization of retinitis pigmentosa associated with variants in SNRNP200
gan: Yusuf, IH, et al.
Cyhoeddwyd: (2019)

RNA editing for Usher syndrome using CRISPR-Cas13
gan: Fry, LE, et al.
Cyhoeddwyd: (2020)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
gan: Han, RC, et al.
Cyhoeddwyd: (2021)

Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial
gan: MacLaren, R, et al.
Cyhoeddwyd: (2014)

Promoter orientation within an AAV-CRISPR vector affects Cas9 expression and gene editing efficiency
gan: Fry, LE, et al.
Cyhoeddwyd: (2020)

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis
gan: Quinn, J, et al.
Cyhoeddwyd: (2024)

"Genetic and clinical findings in an ethnically diverse retinitis pigmentosa cohort associated with pathogenic variants in EYS"
gan: Cundy, O, et al.
Cyhoeddwyd: (2020)

Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review
gan: Buckley, TMW, et al.
Cyhoeddwyd: (2021)

Visual acuity after retinal gene therapy for Choroideremia
gan: Edwards, T, et al.
Cyhoeddwyd: (2016)

In silico analysis of pathogenic CRB1 single nucleotide variants and their amenability to base editing as a potential lead for therapeutic intervention
gan: Bellingrath, J-S, et al.
Cyhoeddwyd: (2021)

Non-viral retinal gene therapy: A review
gan: Issa, P, et al.
Cyhoeddwyd: (2012)

Hypotrichosis and juvenile macular dystrophy caused by CDH3 mutation: A candidate disease for retinal gene therapy
gan: Singh, M, et al.
Cyhoeddwyd: (2016)

Non-viral retinal gene therapy: a review.
gan: Charbel Issa, P, et al.
Cyhoeddwyd: (2012)

Neuroprotective gene therapy for the treatment of inherited retinal degeneration.
gan: Buch, P, et al.
Cyhoeddwyd: (2007)

Non-viral delivery of CRIPSR/Cas cargo to the retina using nanoparticles: current possibilities, challenges, and limitations
gan: Salman, A, et al.
Cyhoeddwyd: (2022)